Echo Street Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
CI
DFO
Echo Street Capital Management's RETA Position: Q2 2021 in Review
Echo Street Capital Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2021, closing a stake of 4,208 shares — an estimated $420K sold.
Echo Street Capital Management first reported a position in RETA in Q1 2021 and held it in 1 quarter. The position peaked at $420K in Q1 2021. 194 funds tracked by Wall St. Rank hold RETA as of Q2 2021.
- Echo Street Capital Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
- Echo Street Capital Management sold 4,208 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2021, an estimated $420K.
- Echo Street Capital Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2021 and held it in 1 quarter.
- Echo Street Capital Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $420K in Q1 2021.
- 194 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2021.
Based on Echo Street Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.